Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
How will private insurance change after ACA in 2026?
Executive Summary
Private insurance under the ACA faces two competing narratives for 2026: most analyses project substantial premium and out‑of‑pocket increases if enhanced premium tax credits expire, while federal rulemaking claims targeted reforms could lower some individual premiums and reduce improper enrollments [1] [2] [3]. The net outcome in 2026 will depend on whether Congress extends enhanced tax credits and how enforcement rules are implemented [4] [2] [3].
1. Clear Claims Drawn From the Analyses — Who Says What, and How Loudly
The assembled analyses make three clear claims: premiums are expected to rise sharply in 2026, the expiration of enhanced premium tax credits will be a primary driver of those increases, and regulatory changes may blunt some cost growth or change enrollment integrity. Multiple pieces state median or average premium increases in the high single digits to double‑digit range: a Peterson‑KFF estimate of an 18% median increase and 20% average [1], KFF and CBPP estimates showing more than doubling of costs for subsidized enrollees if credits lapse [4] [2], and other analyses projecting ~20–26% average increases [5] [6]. These claims present a consistent baseline: tax credit policy is the pivotal factor for 2026 affordability [4] [2].
2. The “Tax Credit Expiration” Scenario — How Bad Could It Be
Analysts focused on the expiration of enhanced premium tax credits portray a severe affordability shock. KFF models show average marketplace premium payments could more than double for subsidized enrollees, with one estimate of a rise from $888 to $1,904 annually — a 114% increase for subsidized households [4]. The Center on Budget and Policy Priorities (CBPP) and similar outlets forecast higher out‑of‑pocket spending and project millions moving off coverage: the Congressional Budget Office scenario cited by CBPP expects 1.5 million additional uninsured in 2026 and 3.8 million by 2035 if enhancements lapse [2]. These analyses emphasize that without legislative action, marketplace affordability would deteriorate sharply [4] [2].
3. The Countervailing Regulatory Story — Can Rulemaking Lower Prices?
Federal rulemaking from CMS offers a different angle: the 2025 Marketplace Integrity and Affordability Final Rule is presented as a tool to lower individual premiums roughly 5% on average and save taxpayers money by reducing improper enrollments and restoring oversight [3]. That change is framed as targeted enforcement rather than a broad subsidy extension, aiming to improve program integrity and lower premiums modestly. Analysts note, however, that a 5% reduction would be small relative to the potential increases tied to tax‑credit expiration. Thus CMS rule benefits may partially offset but not fully neutralize a subsidy‑driven price shock without congressional action [3] [6].
4. Coverage, Cost‑Sharing, and Who Is Most Vulnerable
Beyond headline premiums, analysts stress rising out‑of‑pocket costs and increased deductibles for many households if enhanced tax credits end. CBPP and related analyses estimate typical families could face $1,000–$2,000 higher annual costs, pushing low‑ and moderate‑income families and communities of color to drop coverage or skip care [2]. KFF modeling echoes that subsidized enrollees would bear the brunt, and that affordability declines could translate into substantial increases in the uninsured population [4] [2]. These projections highlight that the policy game here is about both premium price tags and real access to care [4] [2].
5. Contradictions and Consensus — Where Experts Agree and Where They Don’t
There is consensus that policy choices determine the 2026 outcome: extend subsidies and affordability largely holds; let them lapse and premiums and uncovered rates jump [4] [2] [6]. The disagreement is about magnitude and mitigation: CMS claims rule changes will reduce premiums modestly and protect taxpayers, while independent analysts project larger price increases and coverage losses if subsidies lapse (p3_s1 versus [1], p2_s2). These divergent narratives reflect differing emphases — administrative integrity and modest savings versus broad subsidy dependence and large affordability impacts — and suggest the final picture depends on both legislation and implementation [3] [2].
6. The Bottom Line and the Decision Point for 2026
All analyses converge on a simple policy hinge: Congressional extension of enhanced premium tax credits would prevent most of the projected harm, while inaction would make private ACA coverage substantially more expensive for many Americans and likely increase the uninsured population [4] [2] [6]. CMS rule changes offer modest offsets but are unlikely to substitute for subsidy extensions if those subsidies lapse. The 2026 landscape will therefore be shaped by political decisions made before the end of 2025, and by how effectively regulators implement integrity measures while preserving affordability [3] [2].